RvT4 molecule boosts the body’s defenses against atherosclerosis in rheumatoid arthritis patients

Researchers from Queen Mary University of London have found that the molecule RvT4 enhances the body’s natural defences against atherosclerosis (hardening of the arteries) in patients with rheumatoid arthritis.

Medicare to cover more brain scans related to Alzheimer’s drugs

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday. Amyloid

October 13, 2023

Social Isolation Tied to Brain Volume in Older Adults

Frequency of social contact was tied to brain volume in cognitively normal older adults, a cross-sectional study in Japan showed. Total brain volume was smaller

July 13, 2023

One of biotech’s biggest financiers launches small-molecule startup, in spite of IRA’s looming shadow

It’s been nearly a year since Congress passed the Inflation Reduction Act, raising a chorus of drug executive and investor complaints that it would decimate

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.